Close
Open Nav
Program Overview


The BIO Patient & Health Advocacy Summit program is expanding! This year's lineup will feature discussions with thought leaders from the patient advocacy community and the biotechnology industry, as well as several new programs and workshops to make your Summit experience even more fulfilling.


2019 Program

WEDNESDAY, OCTOBER 30

Welcome and Introduction
9:15 AM - 9:30 AM

Practices and Principles: Navigating the FDA
9:30 AM - 10:30 AM

Patients, their caregivers, and patient advocacy organizations engage with the FDA to impact the FDA’s thinking and to influence drug development. This session will address the kind of feedback and engagement the FDA and drug developers are looking for. This panel of patients, patient advocacy organizations, the FDA, and drug developers will discuss recent efforts underway, including the patient-focused drug development initiative, Patient Affairs Staff listening sessions, and PDUFA VII. Learn about opportunities for engagement and hear from patients, caregivers, and patient organizations about their experiences impacting the FDA’s thinking and drug development.

Closing the Gap: Partnering to Invest in Areas of Unmet Need
10:30 AM – 11:30 AM

As the drug development landscape evolves, nonprofit disease foundations are leading the charge to ensure that the patient perspective is integrated throughout the lifecycle of a medical product.  This panel will explore the heart of patient advocacy, how patient-led partnerships can drive therapeutic development particularly in areas of unmet need. Panelists will share key learnings and best practices as well as obstacles and solutions from collaborations.
 

Lunch and Keynote: 2020 Election: Impact on Patient Access
11:30 AM - 1:15 PM

This keynote will provide “insider political baseball” on the 2020 election and the various healthcare policy proposals of presidential candidates including Medicare for All. The affordable care act court case and significant state races will also be covered. Attendees will have the opportunity to ask questions during this session.
 
 
Keynote Speaker: Amy Walter, National Editor of The Cook Political Report 
 
About Amy Walter
 
For more than 20 years, Amy Walter has built a reputation as an accurate, objective, and insightful political analyst with unparalleled access to campaign insiders and decision-makers. Known as one of the best political journalists covering Washington, she is national editor of the non-partisan Cook Political Report and a frequent on-air analyst. In addition to her weekly appearance on the popular “Politics Monday” segment on the PBS NewsHour, Amy also hosts WNYC’s nationally-syndicated public radio news program, “Politics with Amy Walter” on The Takeaway. She is also a regular Sunday panelist on NBC’s Meet the Press and CBS’s Face The Nation, and appears frequently on Special Report with Bret Baier on FOX. She is the former political director of ABC News.
 

Patient Access to Innovative Therapies and the Future of the US Healthcare System
1:45 PM – 3:00 PM

The US is the global leader in ensuring patients have comprehensive access to the newest therapies.  According to research from the US Department of Health and Human Services, US taxpayers pay 1.8 times the international price for medicines and are 'subsidizing' global healthcare. In order to combat this imbalance, the Trump administration is proposing the “International Pricing Index” (IPI) payment model to reduce reimbursement levels for the Centers for Medicare & Medicaid Services (CMS). This panel will explore the potential impact the IPI payment model will have on patient access and innovation.
 

An Overview of Drug Pricing Proposals in Congress and the Administration
3:00 PM - 4:00 PM 

This discussion will review the drug pricing proposals currently in Congress including the Senate’s Prescription Drug Pricing Reduction Act (PDPRA) and, the forthcoming white paper from Democratic Leadership in the House of Representatives. Speakers will also review the President’s importation plan and the ultimate impact these proposals will have on the healthcare system and patients.
 

Where Do We Go From Here?
4:00 PM - 5:00 PM

During this session, panelists will provide reactions to the previous panels on the 2020 election, patient access to innovative therapies, and drug pricing proposals in Congress and the administration.  Panelists will outline where there is alignment within the patient advocacy community, how to move forward, and calls to action.
 

Networking Reception
5:00 PM – 7:00 PM


 

THURSDAY, OCTOBER 31

The Art of Story Telling 
8:30 AM - 10:00 AM

This session will explore how good storytelling can raise awareness of diseases, empower patients and advance policy and/or clinical development. Experts will demonstrate effective storytelling methods for patient advocacy and best strategies for delivering and disseminating the story.
 

Value Assessment Frameworks
10:15 AM – 11:30 AM

How does a patient advocacy group develop the skills needed for health economics—where do you start, where do you go? This panel will discuss how value assessments are used in the US and will provide best practices for patient advocates on how to engage with value assessment frameworks.
 
*Updated as of 9/13/19. Subject to change.

Questions? Contact BIOAllianceDevelopment@bio.org.